1,853 material Form 8-K filings that 1,500 companies we cover made with the SEC in September 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Tortoise Energy Infrastructure Corporation entered into a distribution agreement with PINE Distributors LLC on September 22, 2026, allowing it to sell up to 2,500,000 common shares from time to time at market prices. UBS Securities LLC is a sub-placement agent under the arrangement. Because new shares would increase the share count, existing shareholders could see their ownership percentage diluted if the shares are sold.
Up to 2,500,000 common shares, $0.001 par value, may be sold through PINE Distributors LLC as agent.
UBS Securities LLC is the sub-placement agent under an agreement dated September 22, 2026.
The offering uses a shelf registration statement filed May 8, 2026, with a prospectus supplement dated September 22, 2026.
The filing does not state the price, proceeds, or timing of any sales.
On September 21, 2026, Algorhythm Holdings and Continuation Capital, Inc. agreed to terminate a July 21, 2026 settlement covering liabilities with an original principal of $1,928,014 that CCI had acquired. The settlement had required the company to issue CCI up to 5,000,000 shares of common stock, so ending it removes that potential share issuance, while the company estimates about $1,418,649 of the covered balance remains due.
Settlement agreement dated July 21, 2026 was terminated on September 21, 2026.
The company's obligation to issue up to 5,000,000 shares to CCI, until proceeds reached 120% of the Claim Amount, is terminated.
The company estimates a remaining balance of approximately $1,418,649 due under the liabilities covered by the settlement.
An updated corporate presentation was furnished as Exhibit 99.1 on September 22, 2026.
FortuneX Acquisition Corp (FXAC), a blank check company, signed a business combination agreement on September 18, 2026 with WT Realty Group Inc., a real estate brokerage and services platform. Under the deal, FortuneX will domesticate from the Cayman Islands to Delaware and WT Realty will become a wholly owned subsidiary of the combined public company, with shareholders receiving 60,000,000 shares at a $10.00 reference price. The deal is expected to close in the first quarter of 2027 and requires FortuneX shareholder and WT Realty stockholder approvals.
Aggregate merger consideration of 60,000,000 PubCo shares, implying an equity value of $600 million at a $10.00 reference price
Closing expected in the first quarter of 2027; either party may terminate if closing has not occurred by May 26, 2027
Termination fee of $500,000 payable by a breaching party in specified circumstances
No executed transaction financing commitment identified as of the filing date
QVC Group filed a monthly operating report with the Bankruptcy Court on September 21, 2026, covering August 1-5, 2026, after its Chapter 11 plan took effect on August 6, 2026. The unaudited report shows a loss of $42.3 million on gross sales of $295.8 million for those five days, and negative net worth of $5.84 billion. The company says the figures should not be relied on for investment decisions.
Gross sales of $295.8 million for August 1-5, 2026, with a loss of $42.3 million for the period.
The report shows a cumulative loss of $104.0 million.
Cash at period end was $205.4 million, against total liabilities of $7.89 billion and negative net worth of $5.84 billion.
The report is unaudited, covers a limited period, and is not intended for investment decisions, according to the filing.
United Parks & Resorts named Kyle Miller, its Chief Parks Operations Officer, as President effective September 22, 2026, with CEO Marc Swanson remaining in his role. The company also amended its bylaws to allow the CEO and President roles to be held by separate people, and Chief Commercial Officer Christopher Finazzo said he will resign effective September 25, 2026.
Kyle Miller, 49, appointed President effective September 22, 2026; he has been Chief Parks Operations Officer since January 2023 and joined the company in 1995
Miller's pay includes a $400,000 base salary, a bonus target of 150% of salary, and a long-term incentive target of 300% of salary
Bylaws amended effective September 22, 2026 to allow separate CEO and President roles
Christopher Finazzo notified the company on September 19, 2026 of his resignation as Chief Commercial Officer, effective September 25, 2026
On September 16 and 22, 2026, RTB Digital entered into agreements to sell 494,159 restricted shares of common stock at $11.13 per share, for gross proceeds of $5.5 million, to investors that include entities affiliated with its founders and principal stockholders. In the same period, the company agreed to lend $5.5 million to borrowers at 20% per annum, secured by equity the borrowers own. Shareholders should note the share lock-up schedule, which releases the new shares in four 25% tranches from May 2027 to February 2028.
494,159 shares at $11.13 per share, $5.5 million gross proceeds, sold under Regulation 506(b) without a broker-dealer.
Investors include persons and entities affiliated with founders and principal stockholders.
Lock-up releases of 25% each on May 12, 2027, August 12, 2027, November 12, 2027, and February 14, 2028.
Company lent $5.5 million to borrowers at 20% per annum; the 8-K signature block names RYVYL Inc. rather than RTB Digital.
On September 3, 2026, Plutonian Acquisition Corp. II entered a Business Combination Agreement with NT1 Pty Ltd, an Australian company. NT1's shareholders would transfer all their shares to Purchaser in exchange for 50,000,000 Purchaser Shares, valued at $500 million at a deemed $10.00 per share, and Plutonian II would then merge into a subsidiary of Purchaser. The deal requires Plutonian II shareholder approval and other closing conditions, and the agreement can be terminated if closing has not occurred by June 30, 2027.
Closing Exchange Consideration is 50,000,000 Purchaser Shares, or $500 million at a deemed value of $10.00 per share, subject to possible adjustment after an independent valuation report.
Each Plutonian II ordinary share would convert into the right to receive one Purchaser Share upon the SPAC Merger.
Closing requires Plutonian II shareholder approval, Hart-Scott-Rodino antitrust clearance, and FIRB approval under Australian law.
Either party may terminate if closing has not occurred by June 30, 2027, and a breach can trigger a $500,000 breakup fee plus expenses.
Houlihan Lokey stockholders approved a second amended and restated 2016 Incentive Award Plan at the September 16, 2026 annual meeting, reserving 12 million shares and reducing the automatic annual share increase from 6% to 1%. The board also elected Thomas Reichert as an independent director effective October 1, 2026, and named Prabha Sipi Bhandari Chief Legal Officer after General Counsel Christopher Crain retired.
Proposal 4 (incentive plan) passed with 161,991,591 votes for and 42,486,557 against
Thomas Reichert joins the board effective October 1, 2026, with a $120,000 restricted stock award
Prabha Sipi Bhandari appointed Chief Legal Officer and Secretary on September 16, 2026; Christopher Crain, General Counsel since 2004, became Corporate Senior Advisor
All three director nominees were elected to terms ending at the 2029 annual meeting
iRhythm Holdings disclosed that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act expired at 11:59 p.m. Eastern Time on September 18, 2026, for its previously announced merger with Vital Connect, Inc. The company now expects the acquisition to close in early October 2026, subject to customary closing conditions, which clears a regulatory step before completion.
HSR waiting period expired at 11:59 p.m. Eastern Time on September 18, 2026.
Acquisition of Vital Connect, Inc. is anticipated to close in early October 2026.
Closing remains subject to satisfaction or waiver of customary closing conditions.
Merger agreement was entered into on August 5, 2026, with Fortis Advisors LLC representing Vital Connect stockholders.
On September 17, 2026, Calidi Biotherapeutics agreed to sell 1,025,640 common shares at $1.17 per share in a registered direct offering, which closed September 21, 2026, with gross proceeds of approximately $1.2 million before offering expenses. The company plans to use the net proceeds for working capital and general corporate purposes. The share sale increases the number of shares outstanding, and the company agreed not to issue additional equity for 45 days after closing.
1,025,640 shares sold at $1.17 per share, for gross proceeds of approximately $1.2 million before offering expenses.
Offering closed September 21, 2026; no underwriter or placement agent was engaged, and no underwriting discounts or commissions were paid.
Company agreed not to issue or sell equity or equity-linked securities for 45 days after closing, without consent of holders of more than 50% of the shares sold.
Directors and executive officers agreed to 60-day lock-up agreements, subject to customary exceptions.
Warner Music Group said Carianne Marshall, Co-Chair and Chief Operating Officer of its subsidiary Warner Chappell Music, will step down effective September 30, 2026, and will remain employed through January 8, 2027 to provide transition and advisory services. Her separation agreement provides severance equal to eighteen months of salary, plus bonus eligibility and other payments. The filing does not indicate a change to company financial results, but it reflects a senior leadership departure and related compensation costs.
Carianne Marshall steps down as Co-Chair and COO, Warner Chappell Music, effective September 30, 2026
Marshall remains employed through January 8, 2027 for transition and advisory services
Severance equals eighteen months of salary; also includes a $116,000 lump sum and a one-time equity award with a $1,500,000 grant date value
Full separation agreement, dated September 22, 2026, will be filed with the Form 10-K for the fiscal year ending September 30, 2026
Talos Energy completed its acquisition of deepwater assets in the Gulf of America from Shell Offshore Inc. on September 22, 2026, for a final net cash price of $420 million, which includes a $42.5 million escrow deposit paid earlier. The company also assumed proportionate decommissioning obligations, must provide financial assurance of an estimated $195.5 million, and its borrowing base under the credit agreement rose to $850 million, which matters to shareholders because it changes the company's obligations and borrowing capacity.
Final net cash purchase price at closing was $420 million, including the previously escrowed $42.5 million deposit, subject to customary post-closing adjustments.
Talos holds a 50% working interest and operatorship in the Coulomb field and a 25% non-operated working interest in the BP-operated Na Kika platform and four associated fields.
Initial decommissioning security is estimated at $195.5 million, satisfied through surety bonds at closing; 50% must be provided in cash escrow starting December 31, 2032.
Borrowing base increases from $700 million to $850 million; the company expects about $49 million in letters of credit at closing. Third quarter 2026 results are due November 3, 2026.
LandBridge subsidiary DBR Land Holdings priced an upsized $125 million offering of additional 6.250% senior notes due 2030 at 99.375% of par. The company plans to use the net proceeds to repay part of its revolving credit facility, with closing expected October 1, 2026, subject to customary conditions. The filing covers debt financing only and includes no earnings or guidance information.
Priced $125 million of 6.250% senior notes due 2030 at 99.375% of par, upsized from the previously announced $100 million.
New notes are additional notes under the November 25, 2025 indenture and have identical terms to the $500 million of existing notes.
Offering expected to close October 1, 2026; proceeds to repay a portion of revolving credit facility borrowings.
Halozyme Therapeutics completed the sale of $1,500.0 million of 1.50% Convertible Senior Notes due 2033 on September 22, 2026, including $200.0 million from the initial purchasers' option. The company received net proceeds of approximately $1,471.1 million and plans to use part of them to repurchase existing 2027 and 2028 convertible notes, which adds new debt while potentially reducing older debt.
$1,500.0 million aggregate principal of 1.50% Convertible Senior Notes due 2033 sold, including a $200.0 million option exercise
Net proceeds of approximately $1,471.1 million, with $187.5 million used to fund capped call transactions
Expected repurchases of about $217.0 million of 2027 Notes and about $435.5 million of 2028 Notes, including accrued interest
Initial conversion price of approximately $139.84 per share; interest paid semi-annually starting April 1, 2027
Rocket One Inc. said it signed a definitive membership interest purchase agreement to acquire 100% of Tracer Drone Technologies, LLC, a New Jersey provider of drone hardware, software, training, maintenance and managed services. The closing is subject to customary conditions, and the filing does not state a purchase price, so shareholders cannot yet judge the deal's financial effect.
Agreement executed September 18, 2026; announced September 22, 2026
Rocket One would acquire 100% of Tracer, which would become a wholly owned subsidiary upon closing
Closing depends on satisfaction or waiver of customary conditions; the filing gives no purchase price or financial terms
Energy Vault's indirect subsidiary Development Vault, LLC signed an amended and restated financing agreement on September 18, 2026 for a senior secured delayed draw term loan with up to $25 million in commitments. The loans carry a 10.0% cash interest rate plus a 7.0% payment-in-kind deferred rate, and the filing says $18 million is outstanding and the facility matures April 16, 2030, with the loans secured by substantially all of the borrower's assets.
Facility commitments of up to $25,000,000, with $18 million outstanding as of the A&R Effective Date
Interest of 10.0% per annum payable in cash, plus a 7.0% per annum deferred rate payable in kind
Matures April 16, 2030; proceeds may fund battery energy storage project acquisitions, sponsor equity and project expenses
Secured by a first priority interest in substantially all assets of the borrower and subsidiary guarantors
Caring Brands appointed Brian R. Meadows as full-time Chief Financial Officer effective September 18, 2026, and amended his consulting agreement through Myall Luna Ventures Inc. to cover the role. The monthly consulting fee rose from $10,000 to $15,000, and the board determined Mr. Meadows no longer qualifies as an independent director. The former interim CFO, Brian John, also left the CFO post and resigned as a director and Chairman on September 16, 2026.
Brian R. Meadows named full-time CFO and principal financial officer, effective September 18, 2026
Monthly consulting fee to Myall Luna Ventures Inc. increased from $10,000 to $15,000 under the First Amendment dated September 18, 2026
Brian John ceased as Interim CFO and principal accounting officer and resigned as director and Chairman on September 16, 2026; Dr. Glynn Wilson appointed Chairman effective September 18, 2026
Quantum X Labs said co-Chief Executive Officer Amihay Hadad stepped down effective immediately on September 22, 2026, and that his decision was not due to any disagreement with the company over operations, policies or practices. Yakov Baranes, co-CEO since May 2026, was appointed sole Chief Executive Officer as of the same date. The filing does not disclose financial results or a successor for any other role.
Amihay Hadad stepped down as Co-Chief Executive Officer, effective September 22, 2026
Hadad's departure was not the result of any disagreement with the company
Yakov Baranes, co-CEO since May 2026, was named sole Chief Executive Officer effective September 22, 2026
Group 1 Automotive closed a private offering of $1.25 billion in senior notes due 2032 and 2035, with net proceeds of about $1,236.0 million. The company plans to use the proceeds, with cash on hand, to fund its pending acquisition of dealership assets and real estate from Hennessy Automobile Companies. The notes add long-term debt, and if the Hennessy deal does not close by the outside date, the 2032 notes must be redeemed at par plus interest.
Two tranches of $625.0 million each: 6.250% notes due February 1, 2032 and 6.625% notes due February 1, 2035
Net proceeds of approximately $1,236.0 million after discounts, commissions and estimated expenses
Hennessy Acquisition must close by January 6, 2027, or the 2032 notes face a special mandatory redemption at 100% of issue price plus accrued interest
Worthington Enterprises reported fiscal 2027 first-quarter results for the three months ended August 31, 2026, with net sales up 13% to $343.9 million and diluted EPS of $0.87 versus $0.70 a year earlier. Adjusted diluted EPS rose to $0.82 from $0.78, and the company declared a quarterly dividend of $0.20 per share.
Net sales rose $40.2 million, or 13%, to $343.9 million, including 6% from acquisitions and 7% from organic growth.
GAAP net earnings increased 22% to $42.6 million; adjusted net earnings rose 3% to $40.1 million.
Free cash flow increased to $54.0 million from $27.9 million, and the company repurchased 335,000 shares for $18.2 million.
Quarterly dividend of $0.20 per share is payable December 29, 2026, to holders of record on December 15, 2026.
LeonaBio disclosed that its Series A Common Warrants, issued in December 2025 in a private placement, became exercisable on September 18, 2026 and remain exercisable until October 19, 2026. If all warrants are exercised for cash, the company would receive approximately $146.2 million, but the filing warns that some may expire unexercised or be exercised on a cashless basis if the resale registration statement is not effective, which would bring in less or no cash.
Warrants cover 23,031,494 common shares at an exercise price of $6.35 per share.
Warrants became exercisable September 18, 2026 and expire to exercise after October 19, 2026.
Full cash exercise would provide approximately $146.2 million of additional capital.
Reborn Coffee received a Nasdaq notice on September 16, 2026, saying it no longer meets the minimum $2,500,000 stockholders' equity requirement for continued listing on the Nasdaq Capital Market. The company reported stockholders' equity of $735,642 in its June 30, 2026 Form 10-Q, and it must submit a plan to regain compliance by November 2, 2026. The notice has no immediate effect on the listing, but the company states there is no assurance its plan will be accepted, and a rejected plan could lead to an appeal to a Nasdaq Hearings Panel.
On September 16, 2026, Nasdaq notified the company that its reported stockholders' equity of $735,642 is below the $2,500,000 minimum under Listing Rule 5550(b)(1).
The company also does not meet Nasdaq's alternative standards for market value of listed securities or net income from continuing operations.
A plan to regain compliance is due by November 2, 2026; if accepted, Nasdaq can grant up to 180 calendar days to regain compliance.
A separate Nasdaq notice about the late June 30, 2026 Form 10-Q was closed on September 16, 2026, after the company filed the report on September 14, 2026.
On September 22, 2026, CoreWeave completed a private offering of $4.2 billion in 2.875% convertible senior notes due April 1, 2033, including $500 million from the full exercise of the initial purchasers' option. The notes are senior unsecured obligations, guaranteed by certain subsidiaries, and can be settled in cash, shares or a combination, at CoreWeave's election. For shareholders, the notes add debt and could dilute holders on conversion, with up to 52,578,540 shares issuable at the maximum conversion rate, while capped call transactions are intended to reduce that dilution.
Notes total $4.2 billion, including $500 million from the full exercise of the initial purchasers' option; they bear 2.875% interest, payable April 1 and October 1, beginning April 1, 2027.
Initial conversion price is approximately $97.85 per share, a premium of about 22.50% over the September 17, 2026 last reported sale price of $79.88.
A maximum of 52,578,540 Class A shares may be issued on full conversion, based on the maximum conversion rate of 12.5187 shares per $1,000 principal amount.
CoreWeave may redeem the notes for cash from April 5, 2030 under certain conditions; holders may require repurchase at par plus accrued interest after a fundamental change.
KB Home reported results for the quarter ended August 31, 2026. Revenues fell 20% to $1.30 billion, net income dropped to $65.3 million from $109.8 million, and diluted earnings per share were $1.05, down from $1.61. Management kept its full-year 2026 deliveries, housing revenue and margin guidance within the ranges it last gave, but the lower quarterly profit reduces earnings for shareholders.
Revenues were $1.30 billion, down 20%, and homes delivered fell 19% to 2,732.
Housing gross profit margin was 16.5%, compared to 18.2%, and homebuilding operating income was $67.1 million, compared to $131.2 million.
Net orders fell 12% to 2,604, while backlog value rose 3% to $2.05 billion.
Full-year 2026 guidance was not changed; fourth-quarter deliveries are expected at 3,000 to 3,500 homes.
TriSalus Life Sciences said it received FDA 510(k) clearance for its TriNav Advance device, an addition to its Pressure-Enabled Drug Delivery portfolio. The company expects to begin commercialization with the clearance and plans a limited market release over the coming weeks.
FDA 510(k) clearance announced September 22, 2026 for TriNav Advance
Device can be used in telescoping configuration with a compatible microcatheter to reach smaller, distal vessels, or in high-flow configuration without one
Company intends to initiate a limited market release over the coming weeks
ProPetro said its PROPWR unit has signed new long-term contracts to commit about 230 megawatts of power generation capacity to a subsidiary of Targa Resources Corp., a Permian Basin energy infrastructure company. With these contracts, total capacity committed under contract for PROPWR is about 510 MW, after removing previously announced oil and gas power capacity that is no longer committed.
New contracts commit about 230 MW of behind-the-meter power to a Targa subsidiary.
Total capacity committed under contract for PROPWR is now about 510 MW.
Full deployment is expected in early 2028, and the company says it may make additional megawatts available for data center deployments in 2027 and beyond.
Domo, Inc. completed the sale of substantially all of its assets and employees to Progress Software Corporation on September 22, 2026, and received approximately $221.0 million in cash. The company renamed itself Huckleberry.ai, Inc., repaid its credit facility in full, and says it is now debt-free while retaining more than $900 million in net operating loss carryforwards.
Received approximately $221.0 million in cash at closing on September 22, 2026, or about $4.46 per share according to the press release.
Loan and Security Agreement dated August 8, 2023 terminated; all borrowings and accrued interest and fees paid in full.
Warrants issued in February 2024 and August 2024 repurchased for approximately $10.0 million in aggregate.
Common stock to trade as HUCK on the Nasdaq Global Market effective September 24, 2026, replacing the DOMO symbol; Josh James continues as CEO.
Progress Software completed its purchase of substantially all assets and certain assumed liabilities of Domo's AI and data platform business on September 22, 2026, under an agreement dated July 22, 2026. Progress paid $400 million in cash, funded from cash on hand and an existing revolving credit facility. The filing does not give the deal's financial impact, which Progress says it will discuss on its third-quarter earnings call, and financial statements will follow in an amendment.
Purchase price of $400 million in cash, funded by cash on hand and an existing revolving credit facility
Domo adds a customer base of over 2,400 businesses, according to the press release
Progress will address the financial impact on its third-quarter earnings call on Wednesday, September 30, 2026, at 5:00pm ET
Pro forma and financial statements for the Transaction will be filed by amendment to this 8-K
Tenet Healthcare issued $2 billion of 6.250% senior notes due 2034 on September 22, 2026. The company plans to use the net proceeds, with cash on hand, to redeem its $1.5 billion of 5.125% secured notes due 2027 and partly redeem $0.5 billion of its 6.125% notes due 2028. The deal refinances existing debt, and the filing does not state a change in total debt outstanding.
Issued $2,000,000,000 of 6.250% senior notes due 2034 on September 22, 2026
Proceeds, with cash on hand, to fund redemption of all $1.5 billion of 5.125% senior secured first lien notes due November 2027
Partial redemption of $0.5 billion of 6.125% senior notes due October 2028
Notes are redeemable at a make-whole premium before September 15, 2029, and at set redemption prices after that date
Agree Limited Partnership, a subsidiary of Agree Realty Corporation, completed a $400 million underwritten offering of 5.650% notes maturing October 15, 2036, with the parent and certain subsidiaries guaranteeing the debt. The offering closed September 22, 2026 with net proceeds of approximately $390.1 million after the underwriting discount and estimated expenses, adding to the company's debt load.
Notes: $400 million principal, 5.650% interest, maturing October 15, 2036
Underwriters paid 97.847% of principal; offering closed September 22, 2026
Estimated net proceeds to the issuer of approximately $390.1 million
Indenture includes limits on additional indebtedness and a requirement to maintain unencumbered assets
Aytu BioPharma reported fiscal 2026 fourth-quarter net revenue of $16.1 million, up 6.4% from $15.1 million a year earlier, and a net loss of less than $0.1 million, versus a $19.8 million loss in the prior-year quarter. For the full year, net revenue fell 13.3% to $57.6 million and the net loss widened to $14.3 million from $13.6 million, while Adjusted EBITDA was negative $3.7 million compared with $9.2 million, reflecting planned investments in the EXXUA launch.
Q4 fiscal 2026 net revenue was $16.1 million versus $15.1 million; EXXUA contributed $3.9 million and ADHD Portfolio revenue fell to $10.4 million from $13.1 million.
Full-year fiscal 2026 net revenue was $57.6 million versus $66.4 million, and full-year net loss was $14.3 million, or ($1.16) per share, versus $13.6 million, or ($2.16) per share.
Q4 Adjusted EBITDA was $0.5 million versus $2.0 million a year earlier; cash and cash equivalents were $26.3 million at June 30, 2026, compared with $31.0 million at June 30, 2025.
The company scheduled a conference call and webcast for September 22, 2026, at 4:30 p.m. Eastern time.
Wynn Resorts' subsidiaries issued $900 million of 6.875% senior notes maturing March 15, 2035, under an indenture dated September 22, 2026. Net proceeds, with cash on hand, will redeem the 5.250% senior notes due 2027 of Wynn Las Vegas, LLC, and pay issuance fees and expenses. The filing describes new debt replacing a smaller existing obligation, with covenants limiting sale-leasebacks, liens and mergers.
Notes: $900 million aggregate principal, 6.875%, maturing March 15, 2035
Proceeds plus cash on hand to redeem in full the 5.250% senior notes due 2027 of Wynn Las Vegas, LLC
Interest paid semi-annually on March 15 and September 15, starting March 15, 2027
Change of control repurchase price is 101% of principal plus accrued interest
Helmerich & Payne's board ratified pay increases for CEO Trey Adams and CFO Todd Scruggs, effective October 1, 2026. Adams' base salary rises to $1,000,000 and Scruggs' to $570,000, with higher target bonus and equity award levels for fiscal 2027. The changes raise executive pay costs, but the filing discloses no financial results or performance effects.
CEO Trey Adams' base salary increases to $1,000,000 effective October 1, 2026
Adams' target bonus rises to 130% of base salary and target long-term equity award to 500% of base salary for fiscal 2027
CFO Todd Scruggs' base salary increases to $570,000 effective October 1, 2026, with target bonus at 100% of base salary for fiscal 2027
Board ratified the changes on September 16, 2026, based on Human Resources Committee approval
On September 16, 2026, SCWorx closed a private placement of 350,000 shares of common stock, each sold with a warrant, to ten accredited investors at $2.68 per share and warrant, for gross proceeds of $938,000 before offering expenses. The filing says the company's shares are not currently trading on The Nasdaq Capital Market, and if trading does not resume by October 31, 2026, purchasers can require the company to return their subscription amounts, which would reverse the sale.
350,000 shares and 350,000 warrants sold at $2.68 per share and accompanying warrant; gross proceeds $938,000; closed September 16, 2026.
Warrants have an exercise price of $2.56 per share, are exercisable immediately and expire on the fifth anniversary of the initial exercise date.
Placement agent Dawson James Securities receives 49,860 fee shares and a cash fee of 5.0% of gross proceeds, plus expenses up to $50,000.
Purchasers may require cash repayment of their subscription amounts if the stock does not resume trading on Nasdaq by October 31, 2026.
Heritage Global Inc. entered into a $10.0 million revolving line of credit with C3bank, National Association, on September 16, 2026, maturing January 16, 2028. The facility is secured by company and subsidiary assets and a pledge of subsidiary equity, and carries restrictions on additional borrowing and asset encumbrance.
Revolving line of credit of $10.0 million with C3bank, National Association, dated September 16, 2026
Maturity date of January 16, 2028; interest at prime rate plus 1.00%, with a floor of 7.500% per annum
Secured by company and subsidiary assets and a pledge of subsidiary equity; proceeds limited to business operations
Full agreements to be filed as exhibits to the Form 10-Q for the quarter ended September 30, 2026
Curtiss-Wright's Board appointed Chief Operating Officer Kevin M. Rayment as President and Chief Executive Officer, effective January 1, 2027, and as a Board member at that time. Lynn M. Bamford, CEO since January 2021, will retire as CEO and become Executive Chair on the same date. The filing describes a planned succession, and Rayment's base salary and incentive targets are set out in the filing.
Kevin M. Rayment, age 57, joined the company in 2004 and has served as COO since April 2021 and as Executive Vice President since January 2026.
Rayment's annual base salary will be $1,100,000, with an annual target bonus of 125% of base salary.
Rayment's 2027 long-term incentive award has a target value of $5,225,000, split 30% restricted stock units, 30% performance units and 40% performance share units.
Bamford joined the company over 22 years ago and has been Chair since May 2022.
Hennessy Capital Investment Corp. VII (HVII) and ONE Nuclear entered into a forward purchase agreement dated September 22, 2026, with New Circle Capital Solutions LP, tied to their pending business combination. The filing says the final redemption payment and per-share price cannot be determined until the combination closes, and it links the deal to HVII shareholder redemption requests.
New Circle may buy up to 5,000,000 HVII Class A ordinary shares from third parties and will be prepaid an amount equal to the shares multiplied by the per-share redemption price at closing.
The prepayment is due on the earlier of one business day after closing or the date trust account assets are disbursed for the combination.
As of September 18, 2026, the redemption price was approximately $10.60 per share, and shareholders had submitted requests to redeem 18,796,132 shares.
The agreement matures 90 days after the business combination closes, unless extended in writing.
i-80 Gold filed a Pre-Feasibility Study for its Granite Creek Underground Project, dated September 21, 2026, with an effective date of March 31, 2026. The study reports an after-tax NPV (5%) of $118 million and a mine life of 8.5 years at a $2,750 per ounce gold price, and it supersedes the March 2025 Preliminary Economic Assessment.
After-tax NPV (5%) of $118 million and pre-tax NPV of $138 million at a $2,750 per ounce gold price
Proven and probable mineral reserves of 2,198 thousand tonnes at 7.87 g/t gold, containing 556.5 thousand ounces
Life-of-mine total cash costs of $2,076 per ounce and all-in sustaining costs of $2,273 per ounce, with total capital and closure costs of $144.9 million
Study prepared by third-party firms including SRK Consulting (U.S.), Inc. and Hatch Associates Consultants, Inc., with an effective date of March 31, 2026
BlackBerry and Vector announced that Coretura, the software-defined vehicle platform company founded by Daimler Truck and Volvo Group, has selected Alloy Kore as the first design win for the jointly developed vehicle OS. The company says the win adds over $100 million to the QNX royalty backlog and is the largest design win in QNX history, though backlog is an estimate and may not reflect actual future revenue.
Coretura selected Alloy Kore, the foundational software layer jointly developed by QNX and Vector, as the first design win for the product.
The design win adds over $100 million to the QNX royalty backlog, which the company describes as estimated future revenue from variable forecasted royalties.
The filing says the win is the largest design win in QNX history and warns that actual revenue depends on production volumes and possible contract changes or terminations.
The announcement is dated September 22, 2026, and the press release is furnished as Exhibit 99.1.
Lucid Diagnostics said three public meetings in mid-September advanced payment, billing and coding pathways for its EsoGuard and EsoCheck tests. The filing reports no financial results, and the outcomes remain subject to final determinations, public comment periods and effective dates.
A CMS Medicare Advisory Panel meeting on September 15-16 recommended keeping EsoGuard's original gapfill payment basis under PLA code 0114U; CMS expects final determinations in November.
The AMA CPT Editorial Panel approved a new Category III CPT code for nonendoscopic esophageal cell collection on September 17-19.
Lucid says it will begin submitting Medicare claims this month for tests at its Texas lab, while claims from its California lab await a final revised LCD.
Effective September 21, 2026, Jamaal T. Lesane became Executive Vice President and Chief Legal Officer of Madison Square Garden Sports Corp. and stopped serving as Chief Operating Officer. Bryan Warner, Senior Vice President and Head of Legal, ceased to be an executive officer on the same date but remains employed with the same title under his existing employment agreement. The filing describes changes in the company's senior legal and operating leadership, with no financial figures disclosed.
Jamaal T. Lesane became Executive Vice President and Chief Legal Officer effective September 21, 2026
Lesane ceased to serve as Chief Operating Officer as of the same date
Bryan Warner ceased to be an executive officer effective September 21, 2026 but keeps his Senior Vice President, Head of Legal title
The filing is dated September 22, 2026 and was signed by Mark C. Cresitello, Senior Vice President, Deputy General Counsel and Secretary
Upbound Group said Scott Young joined as Executive Vice President and Chief Operating Officer effective September 22, 2026, reporting to CEO Fahmi Karam. The company said the newly created role will lead strategic alignment across Acima, Brigit and Rent-A-Center, and it also named Dev Chakraborty Senior Vice President and Head of Brigit.
Scott Young's offer letter sets an annual base salary of $610,000 and a cash bonus target of 60% of base salary.
Young receives a one-time sign-on award of Performance Stock Units valued at $3,111,000, earned based on stock price hurdles over four years.
Starting February 2027, Young is eligible for a long-term incentive target of 170% of base salary.
Dev Chakraborty, formerly General Manager at MoneyLion, was named SVP and Head of Brigit; the company cited Brigit at approximately $300 million in annual recurring revenue and 1.8 million paying users.
Columbus McKinnon amended its credit agreement on September 21, 2026, refinancing its $1,452.9 million Term Loan B and reducing the interest rate margin on both the term loan and its $500 million revolver by 0.50% per annum. The company expects the change to cut annual cash interest expense by at least $7.3 million, which would give shareholders a modest boost to cash flow, though the filing contains no new earnings figures.
Term Loan B refinanced in an aggregate principal amount of $1,452.9 million, with margin reduced by 0.50% per annum
Revolving Facility margin also reduced by 0.50%; dollar term SOFR margin now ranges from 1.75% to 2.75% based on leverage
Company expects annual cash interest expense to fall by at least $7.3 million; maturity dates unchanged
Amendment signed September 21, 2026 and announced in a September 22, 2026 press release
Idaho Copper received a U.S. Forest Service letter approving its Exploration Plan of Operations and 2026 annual operating plan for the CuMo project in Boise County, Idaho, clearing the way for drilling and road-building. The company says the approval removes the remaining administrative conditions and lets it start work, with up to 15,000 feet of diamond core drilling targeted this season.
Forest Service letter approving the Exploration Plan of Operations and 2026 annual operating plan; USFS accepted the company's reclamation surety bond on or before the letter date
USFS accepted the signed Forest Service Evaluation form on September 9, 2026
Company is targeting up to 15,000 feet of additional diamond core drilling this season, with a larger campaign planned for 2027 toward a Prefeasibility Study
XFLH Capital Corporation, a blank check company, entered into a non-binding letter of intent on September 18, 2026 for a proposed business combination with Renogen Biolab Inc., a Canadian health service provider offering DNA services, vector engineering, and protein expression. The parties agreed to negotiate definitive agreements and to give each other access to information for due diligence, but the filing discloses no deal terms, valuation, or closing timeline, and no definitive agreement has been signed.
Letter of intent entered September 18, 2026; announced in a press release dated September 22, 2026
Letter of intent is non-binding; parties will use reasonable best efforts to negotiate definitive agreements
Filing discloses no valuation, consideration, or closing timeline for the proposed combination
If a definitive agreement is signed, the company says it will prepare a proxy statement for stockholders
Compass Therapeutics said the FDA recommended it conduct a trial demonstrating a survival benefit before submitting a Biologics License Application for tovecimig in previously treated advanced biliary tract cancer. The company said it does not believe a new trial is warranted before submission and will keep engaging with the FDA, which means the timing and path to approval are now uncertain.
FDA recommended a trial demonstrating a survival benefit before a BLA submission for tovecimig
Phase 2/3 COMPANION-002 showed ORR of 18.0% vs. 5.3% with paclitaxel alone (p=0.0228)
Median progression-free survival was 4.7 vs. 2.6 months, hazard ratio 0.44 (p<0.0001)
Overall survival analyses did not reach statistical significance due to crossover
i-80 Gold furnished a September 21, 2026 press release on a feasibility study for its Granite Creek Underground gold project in Nevada. The base case shows an after-tax NPV (5%) of $118 million at $2,750/oz gold, rising to $598 million at $4,500/oz, and the study reports initial reserves of 556,500 oz gold. The filing also furnishes Mineral Point assay results, and the company says the study's production and sustaining capital figures improved on the March 2025 preliminary economic assessment.
Base case at $2,750/oz gold: after-tax NPV (5%) of $118 million and undiscounted after-tax cash flow of $153 million.
Initial proven and probable reserves of 2.20 million tonnes grading 7.87 g/t gold, containing 556,500 oz gold; mine life of about 8.5 years.
Average annual gold production of about 75,000 oz from 2028 to 2032, versus the March 2025 PEA; sustaining capital of $83 million, which the company says is lower than the PEA.
Lone Tree Plant commissioning is planned for the fourth quarter of 2027; inferred resources fell 38% as infill drilling upgraded material to higher categories.
GE Aerospace's independent directors appointed Wesley Bush as independent Lead Director effective September 21, 2026, succeeding Tom Horton, who remains on the Board. The Board also appointed director Judson Althoff to the Audit Committee effective the same date. The changes are governance updates with no financial figures disclosed.
Wesley Bush appointed independent Lead Director effective September 21, 2026
Tom Horton, Lead Director since 2018, remains a Board member
Judson Althoff appointed to the Audit Committee effective September 21, 2026, after joining the Board effective June 24, 2026
The FDA has lifted the full clinical hold on Filana Therapeutics' IND for a planned Phase 2a study of simufilam in TSC-related epilepsy. Patient screening is expected to begin by the first quarter of 2027, so the hold removal is a development milestone rather than a change in financial results.
FDA lifted the full clinical hold on the simufilam IND, announced September 22, 2026
Planned Phase 2a study: 16-week randomized, double-blind trial at 13 U.S. sites, targeting 40 subjects aged 12 to 55
Patient screening expected to begin by the first quarter of 2027
Company completed trial-readiness work during the hold, including engaging a clinical research organization and identifying sites
Fiserv's Chief Administrative Officer and Chief Legal Officer, Adam L. Rosman, resigned on September 16, 2026, effective September 30, 2026. General Counsel and Secretary Eric C. Nelson will succeed him as Chief Legal Officer on October 1, 2026. The filing does not describe the reason for the departure or any financial effect.
Adam L. Rosman resigned as Chief Administrative Officer and Chief Legal Officer on September 16, 2026, effective September 30, 2026
Eric C. Nelson, current General Counsel and Secretary, becomes Chief Legal Officer on October 1, 2026
The filing does not state a reason for the resignation or name a successor for the Chief Administrative Officer role
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.